Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

447.52
Delayed Data
As of Apr 17
 -9.90 / -2.16%
Today’s Change
269.50
Today|||52-Week Range
495.50
+9.08%
Year-to-Date

Today’s Trading

Previous close457.42
Today’s open451.58
Day’s range442.60 - 455.78
Volume676,056
Average volume (3 months)825,330
Market cap$46.9B
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+5.20%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio145.8
Price/Sales14.64
Price/Book18.43

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-4.39-3.62%
QQuintiles Transnatio...-0.79-1.17%
ISISIsis Pharmaceuticals...-0.98-1.48%
ICLRICON PLC+0.14+0.20%
Data as of 4:04pm ET, 04/17/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$2.68
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers